Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pediatrix Medical GroupFRA:PDC +5.71%55 Equity-to-Asset is 0.41 as of Jun. 2026, which is 5% above its 10-year median of 0.39. GuruFocus rates FRA:PDC with a GF Score™ of 55/100 and a GF Value™ of €11.41. The stock has 8 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Pediatrix Medical Group ranks worse than 58.71% on this metric.
The historical rank and industry rank for Pediatrix Medical Group's Equity-to-Asset or its related term are showing as below:
FRA:PDC'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.22 Med: 0.39 Max: 0.54
Current: 0.41
During the past 13 years, the highest Equity to Asset Ratio of Pediatrix Medical Group was 0.54. The lowest was 0.22. And the median was 0.39.
FRA:PDC's Equity-to-Asset is ranked worse than 58.71% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 0.48
vs FRA:PDC: 0.41
Pediatrix Medical Group (FRA:PDC) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Pediatrix Medical Group Equity-to-Asset Related Terms
Pediatrix Medical Group Equity-to-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PDC vs ADUS, AVAH, SGRY: Equity-to-Asset Comparison
For the Medical Care Facilities subindustry, Pediatrix Medical Group's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pediatrix Medical Group Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pediatrix Medical Group's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Pediatrix Medical Group's Equity-to-Asset falls into.
Pediatrix Medical Group Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Pediatrix Medical Group's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pediatrix Medical Group (FRA:PDC) has a Equity-to-Asset of 0.41 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Pediatrix Medical Group and its competitors. This is near median its historical median of 0.39. Over the past decade, Pediatrix Medical Group's Equity-to-Asset has ranged from 0.22 to 0.54. According to the industry distribution chart, Pediatrix Medical Group ranks #401 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 58.7%.
Is Pediatrix Medical Group's Equity-to-Asset too high?
Pediatrix Medical Group's current Equity-to-Asset of 0.41 is near median its 10-year median of 0.39. Over the past 10 years, this metric has ranged from a low of 0.22 to a high of 0.54. The Healthcare Providers & Services industry median Equity-to-Asset is 0.48. Pediatrix Medical Group's value of 0.41 is 14.6% below this industry median. Based on the distribution chart, Pediatrix Medical Group ranks #401 out of 683 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Pediatrix Medical Group has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does Pediatrix Medical Group's Equity-to-Asset compare to ADUS and AVAH?
According to the Healthcare Providers & Services industry distribution chart, Pediatrix Medical Group ranks #401 out of 683 companies for Equity-to-Asset. This places Pediatrix Medical Group in the lower half of its industry. The industry median Equity-to-Asset is 0.48. Pediatrix Medical Group's value of 0.41 is 14.6% below this benchmark. Historically, Pediatrix Medical Group's own Equity-to-Asset has ranged from 0.22 to 0.54 over the past decade. While the company's 10-year median is 0.39 vs. the industry median of 0.48, Pediatrix Medical Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.48, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pediatrix Medical Group's current Equity-to-Asset of 0.41 is 14.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Pediatrix Medical Group and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pediatrix Medical Group's current Equity-to-Asset is 0.41, which is near median its own 10-year median of 0.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pediatrix Medical Group stock overvalued right now?
Pediatrix Medical Group (FRA:PDC) has a current Equity-to-Asset of 0.41. The stock's GF Value™ is €11.41, compared to a current price of €22.20 — trading 94.6% above its estimated fair value. The current Equity-to-Asset is 0.41, which is near median its 10-year median of 0.39 and 14.6% below the Healthcare Providers & Services industry median of 0.48. Pediatrix Medical Group's overall GF Score™ is 55/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Pediatrix Medical Group (FRA:PDC), the current Equity-to-Asset is 0.41 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pediatrix Medical Group (FRA:PDC) Overvalued in 2026?
Based on GuruFocus' analysis, Pediatrix Medical Group stock appears to be overvalued.
The current stock price of €22.20 is trading 94.6% above its estimated GF Value™ of €11.41.
Key valuation signals for FRA:PDC:
Equity-to-Asset: 0.41 (near median its 10-year median of 0.39)
GF Value™: €11.41 vs. price of €22.20 (94.6% above fair value)
Industry Position: 14.6% below the Healthcare Providers & Services median (#401 of 683)
No single metric tells the full story. See the FRA:PDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
55GF Score
Get the complete analysis for FRA:PDC
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PDC has been successfully added to your 
